ZNF460 Promotes GSDME-Driven Pyroptosis via PKM2 Transcriptional Activation in Aortic Dissection
Open Access
- 18 March 2026
- journal article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (3)
Abstract
Background: Aortic dissection (AD) is a cardiovascular emergency with high mortality; however, the underlying molecular pathophysiology of AD remains incompletely understood. Pyroptosis, a proinflammatory form of programmed cell death, contributes to vascular injury; nonetheless, the upstream transcriptional regulation of pyroptosis in AD is similarly poorly defined. Methods: Differentially expressed genes were identified in aortic tissues from AD patients (Gene Expression Omnibus (GEO) datasets) using bioinformatics analyses, with a focus on cell death-related candidates. In vivo AD mouse models and in vitro vascular smooth muscle cell (VSMC) systems were employed to investigate the roles of these genes in AD. Potential transcription factors for pyruvate kinase M2 (PKM2) were predicted using the Just Another Simple Array Retrieval/Simple API for Repository (JASPAR) and University of California, Santa Cruz (UCSC) databases, and validated by luciferase reporter and chromatin immunoprecipitation assays. Gain- and loss-of-function approaches were used to dissect the zinc finger protein 460 (ZNF460)–PKM2–gasdermin E (GSDME) axis and the associated impact on pyroptosis and AD progression. Results: PKM2 expression was markedly elevated in AD tissues. PKM2 silencing suppressed GSDME cleavage, attenuated VSMC pyroptosis, and mitigated experimental AD, whereas PKM2 overexpression aggravated these outcomes. GSDME upregulation rescued pyroptosis in PKM2-depleted cells. Mechanistically, the transcription factor ZNF460 directly bound to the PKM2 promoter, enhancing PKM2 transcription and activating downstream GSDME-mediated pyroptosis. ZNF460 knockdown reduced pyroptotic cell death and preserved aortic wall integrity in vivo. Conclusions: This study identifies ZNF460 as a novel upstream regulator of PKM2 that drives GSDME-dependent pyroptosis, thereby exacerbating AD progression. Targeting the ZNF460–PKM2–GSDME axis may represent a promising therapeutic strategy for preventing pyroptosis-driven vascular damage in AD.Keywords
Funding Information
- Foundation of Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University (XHZDSYS202406)
- National Natural Science Foundation of China (82070476)
- National Natural Science Foundation of China (82300543)
- Joint Funds for the Innovation of Science and Technology, Fujian province (2023Y9219)
This publication has 32 references indexed in Scilit:
- Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapyCell Metabolism, 2025
- Identification of PKM2 as a pyroptosis-related key gene aggravates senile osteoporosis via the NLRP3/Caspase-1/GSDMD signaling pathwayThe International Journal of Biochemistry & Cell Biology, 2024
- Macrophage-derived GSDMD promotes abdominal aortic aneurysm and aortic smooth muscle cells pyroptosisInternational Immunopharmacology, 2024
- Role of Pyruvate Kinase M2 (PKM2) in Cardiovascular DiseasesJournal of Cardiovascular Translational Research, 2022
- Pyruvate kinase M2 (PKM2) in cancer and cancer therapeuticsCancer Letters, 2021
- Role of pyroptosis in atherosclerosis and its therapeutic implicationsJournal of Cellular Physiology, 2021
- Shikonin attenuates acetaminophen-induced acute liver injury via inhibition of oxidative stress and inflammationBiomedicine & Pharmacotherapy, 2019
- GSDME mediates caspase-3-dependent pyroptosis in gastric cancerBiochemical and Biophysical Research Communications, 2018
- Acute Type A Aortic DissectionCardiology Clinics, 2017
- Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated MacrophagesCell Metabolism, 2015